5-Methylpyrimidine-2-carbaldehyde

Catalog No. :
ACUYCA915
CAS No. :
90905-62-7
Molecular Formula :
C6H6N2O
Molecular Weight :
122.13

IUPAC Name:5-methylpyrimidine-2-carbaldehyde

5-Methylpyrimidine-2-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$81.00Login to see priceIn stockInquiry
100mg95%$134.00Login to see priceIn stockInquiry
250mg95%$271.00Login to see priceIn stockInquiry
1g95%$681.00Login to see priceIn stockInquiry
5g95%$2049.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Methylpyrimidine-2-carbaldehyde
IUPAC Name5-methylpyrimidine-2-carbaldehyde
MDL No.MFCD10697092
Molecular FormulaC6H6N2O
Molecular Weight122.13
SMILESCC1=CN=C(C=O)N=C1
InChI KeyOBPDHHJZPOGJPO-UHFFFAOYSA-N
Synonym5-Methylpyrimidine-2-carbaldehyde | 90905-62-7 | SCHEMBL3901574 | 5-methyl-2-pyrimidinecarbaldehyde | DTXSID20630000 | OBPDHHJZPOGJPO-UHFFFAOYSA-N | 5-Methylpyrimidine-2-carboxaldehyde | MFCD10697092 | AKOS006304592 | PB31489 | AS-34492 | 2-Pyrimidinecarboxaldehyde,5-methyl-(9
CAS No.90905-62-7
PubChem CID23043336

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACUYCA915 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDTNZ781 route compound structure diagram
    ACDTNZ78190905-61-6 In Stock
  2. Then
  3. ACUYCA915 route product structure diagram
    ACUYCA91590905-62-7 In Stock
Inquiry

2. ACUYCA915 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUYCA915 route product structure diagram
    ACUYCA91590905-62-7 In Stock
Inquiry

Comments (0)